Patient Community Events
Informational Webcast on avapritinib Clinical Trial Program
On Thursday, November 30, Blueprint Medicines hosted an informational webcast for the GIST patient community about avapritinib, an investigational medicine for people with advanced GIST, in collaboration with The Life Raft Group and GIST Support International.
During the webcast, Dr. Andy Boral, Chief Medical Officer of Blueprint Medicines, shared an update on avapritinib, including a summary of updated clinical trial results recently presented at The Connective Tissue Oncology Society 2017 Annual Meeting on November 10. Dr. Boral also provided an update on ongoing and planned avapritinib clinical trials.
A replay of the website is available below. Patients and caregivers who have additional questions that were not addressed during the webinar can email the Blueprint Medicines team at firstname.lastname@example.org.